Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CLINICAL MEASUREMENT - ANNOTATIONS

The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).

Term:nervous system disease measurement
go back to main search page
Accession:CMO:0002364 term browser browse the term
Definition:Any quantitative or qualitative value which is the result of an act of assessing a state or property related to a disease, lesion or abnormality of the nervous system in a single individual or a group of individuals, based on direct observation or experimental manipulation.
Synonyms:xref: MESH:D009422



show annotations for term's descendants           Sort by:
 
encephalitis incidence/prevalence measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Vie1 Viral induced encephalitis QTL 1 IDA RGD PMID:22761571 RGD:7240516 NCBI chr 4:34,430,484...82,490,359 JBrowse link
Q Vie2 Viral induced encephalitis QTL 2 IDA RGD PMID:22761571 RGD:7240516 NCBI chr 3:145,956,084...169,034,231 JBrowse link
Q Vie3 Viral induced encephalitis QTL 3 IDA RGD PMID:22761571 RGD:7240516 NCBI chr 6:96,833,997...140,994,061 JBrowse link
Q Vie4 Viral induced encephalitis QTL 4 IDA RGD PMID:22761571 RGD:7240516 NCBI chr 4:62,933,508...82,490,359 JBrowse link
Q Vie5 Viral induced encephalitis QTL 5 IDA RGD PMID:22761571 RGD:7240516 NCBI chr 4:34,430,484...82,490,359 JBrowse link
experimental autoimmune encephalomyelitis incidence/prevalence measurement term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae12 Experimental allergic encephalomyelitis QTL 12 IDA RGD PMID:10545597 RGD:69695 NCBI chr10:92,238,497...101,012,337 JBrowse link
Q Eae13 Experimental allergic encephalomyelitis QTL 13 IDA RGD PMID:10545597 RGD:69695 NCBI chr12:24,139,202...36,638,073 JBrowse link
Q Eae14 Experimental allergic encephalomyelitis QTL 14 IDA RGD PMID:10545597 RGD:69695 NCBI chr13:23,203,448...68,203,448 JBrowse link
Q Eae15 Experimental allergic encephalomyelitis QTL 15 IDA RGD PMID:10545597 RGD:69695 NCBI chr18:76,477,814...77,209,844 JBrowse link
Q Eae16 Experimental allergic encephalomyelitis QTL 16 IDA RGD PMID:12517974 RGD:629629 NCBI chr 8:8,462,195...110,921,472 JBrowse link
Q Eae17 Experimental allergic encephalomyelitis QTL 17 IDA RGD PMID:12517974 RGD:629629 NCBI chr13:8,897,350...101,631,289 JBrowse link
Q Eae2 Experimental allergic encephalomyelitis QTL 2 IDA RGD PMID:9973459 RGD:69694 NCBI chr 4:21,333,343...39,505,420 JBrowse link
Q Eae3 Experimental allergic encephalomyelitis QTL 3 IDA RGD PMID:9973459 RGD:69694 NCBI chr10:26,521,957...61,345,413 JBrowse link
Q Eae4 Experimental allergic encephalomyelitis QTL 4 IDA RGD PMID:10072499 RGD:69712 NCBI chr 9:1...25,661,317 JBrowse link
percentage of study population developing cerebrovascular lesions during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Strs4 Sensitivity to stroke QTL 4 IDA RGD PMID:23690346 RGD:7411685 NCBI chr 1:78,430,536...123,430,536 JBrowse link
Q Strs5 Sensitivity to stroke QTL 5 IDA RGD PMID:23690346 RGD:7411685 NCBI chr18:49,999,958...65,845,095 JBrowse link
Q Strs6 Sensitivity to stroke QTL 6 IDA RGD PMID:23690346 RGD:7411685 NCBI chr 5:134,972,980...138,113,556 JBrowse link
Q Strs7 Sensitivity to stroke QTL 7 IDA RGD PMID:23690346 RGD:7411685 NCBI chr15:40,289,901...49,308,583 JBrowse link
percentage of study population developing experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae20 Experimental allergic encephalomyelitis QTL 20 IDA RGD PMID:15634914 RGD:1547849 NCBI chr 4:153,031,106...158,841,762 JBrowse link
Q Eae24 Experimental allergic encephalomyelitis QTL 24 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:66,993,185...72,752,834 JBrowse link
Q Eae25 Experimental allergic encephalomyelitis QTL 25 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:78,882,817...83,007,655 JBrowse link
Q Eae27 Experimental allergic encephalomyelitis QTL 27 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:103,194,805...112,478,794 JBrowse link
Q Eae8 Experimental allergic encephalomyelitis QTL 8 IDA RGD PMID:10640775 RGD:61031 NCBI chr19:24,816,041...33,061,905 JBrowse link
percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae10 Experimental allergic encephalomyelitis QTL 10 IDA RGD PMID:10640775 RGD:61031 NCBI chr14:17,622,685...18,274,498 JBrowse link
Q Eae5 Experimental allergic encephalomyelitis QTL 5 IDA RGD PMID:10640775 RGD:61031 NCBI chr12:19,610,870...46,669,029 JBrowse link
percentage of study population developing trigeminal nerve neurilemmomas during a period of time term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Schws1 Schwannoma susceptibility QTL 1 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:40,035,094...102,359,817 JBrowse link
Q Schws2 Schwannoma susceptibility QTL 2 IDA RGD PMID:16003739 RGD:1559300
Q Schws3 Schwannoma susceptibility QTL 3 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 3:118,839,124...163,839,124 JBrowse link
Q Schws4 Schwannoma susceptibility QTL 4 IDA RGD PMID:16003739 RGD:1559300 NCBI chr 6:83,190,345...106,747,639 JBrowse link
Q Schws7 Schwannoma susceptibility QTL 7 IDA RGD PMID:16003739 RGD:1559300 NCBI chr10:4,765,527...19,816,042 JBrowse link
Q Schws8 Schwannoma susceptibility QTL 8 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:94,968,928...139,968,928 JBrowse link
Q Schws9 Schwannoma susceptibility QTL 9 IDA RGD PMID:25303613 RGD:11566050 NCBI chr 6:61,747,639...106,747,639 JBrowse link
post-insult time to onset of experimental autoimmune encephalomyelitis term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Eae11 Experimental allergic encephalomyelitis QTL 11 IDA RGD PMID:10640775 RGD:61031 NCBI chr 4:1...39,505,420 JBrowse link
Q Eae22 Experimental allergic encephalomyelitis QTL 22 IDA RGD PMID:15634914 RGD:1547849
Q Eae24 Experimental allergic encephalomyelitis QTL 24 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:66,993,185...72,752,834 JBrowse link
Q Eae25 Experimental allergic encephalomyelitis QTL 25 IDA RGD PMID:19675581 RGD:2317591 NCBI chr 4:78,882,817...83,007,655 JBrowse link
Q Eaex Experimental allergic encephalomyelitis QTL x IDA RGD PMID:10640775 RGD:61031 NCBI chr 5:55,715,622...100,715,622 JBrowse link
post-insult time to trigeminal nerve neurilemmoma formation term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Schws5 Schwannoma susceptibility QTL 5 IDA RGD PMID:16003739 RGD:1559300

Term paths to the root
Path 1
Term Annotations click to browse term
  clinical measurement 2369
    nervous system measurement 63
      nervous system disease measurement 36
        nervous system disease incidence/prevalence measurement + 25
        nervous system disease onset/diagnosis measurement + 6
        nervous system tumor measurement + 8
paths to the root